Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Attanasio

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Expert Review of Clinical Pharmacology|March 7, 2012
Octreotide long-acting repeatable for acromegalyRenato Cozzi, Roberto Attanasio
Expert Review of Endocrinology & Metabolism|February 14, 2019
Octreotide for acromegalyRenato Cozzi, Roberto Attanasio
The Journal of Surgical Research|June 26, 2024
Letter Regarding: Modern Trends for Primary Hyperparathyroidism: Intervening on Less Biochemically Severe DiseaseElena Castellano, Roberto Attanasio, Giorgio Borretta
European Journal of Endocrinology|July 27, 2006
Pregnancy in acromegaly: a one-center experienceRenato Cozzi, Roberto Attanasio, Michela Barausse
Endocrinology, Diabetes & Metabolism Case Reports|October 12, 2018
Hyponatremia after anticoagulant treatment: a rare cause of adrenal failureBenedetta Zampetti, Roberto Attanasio, Renato Cozzi
European Journal of Endocrinology|March 27, 2003
Raloxifene lowers IGF-I levels in acromegalic womenRoberto Attanasio, Michela Barausse, Renato Cozzi
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 6, 2018
THE CLINICAL PRESENTATION OF PRIMARY HYPERPARATHYROIDISM: A SOUTHERN EUROPEAN PERSPECTIVE OVER THE LAST 2 DECADESElena Castellano, Roberto Attanasio, Alberto Boriano, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 21, 2020
False Positive of <sup>68</sup>Ga-DOTATATE PET-CT in a ParagangliomaBenedetta Zampetti, Roberto Attanasio, Marco Boniardi, et al.
Clinical Endocrinology|July 27, 2004
Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin statusRenato Cozzi, Roberto Attanasio, Sandro Lodrini, et al.
Journal of the Endocrine Society|November 21, 2019
Clinical Presentation of Primary Hyperparathyroidism in Older AdultsElena Castellano, Roberto Attanasio, Alberto Boriano, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Expert Review of Clinical Pharmacology|March 7, 2012
Octreotide long-acting repeatable for acromegalyRenato Cozzi, Roberto Attanasio
Expert Review of Endocrinology & Metabolism|February 14, 2019
Octreotide for acromegalyRenato Cozzi, Roberto Attanasio
The Journal of Surgical Research|June 26, 2024
Letter Regarding: Modern Trends for Primary Hyperparathyroidism: Intervening on Less Biochemically Severe DiseaseElena Castellano, Roberto Attanasio, Giorgio Borretta
European Journal of Endocrinology|July 27, 2006
Pregnancy in acromegaly: a one-center experienceRenato Cozzi, Roberto Attanasio, Michela Barausse
Endocrinology, Diabetes & Metabolism Case Reports|October 12, 2018
Hyponatremia after anticoagulant treatment: a rare cause of adrenal failureBenedetta Zampetti, Roberto Attanasio, Renato Cozzi
European Journal of Endocrinology|March 27, 2003
Raloxifene lowers IGF-I levels in acromegalic womenRoberto Attanasio, Michela Barausse, Renato Cozzi
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 6, 2018
THE CLINICAL PRESENTATION OF PRIMARY HYPERPARATHYROIDISM: A SOUTHERN EUROPEAN PERSPECTIVE OVER THE LAST 2 DECADESElena Castellano, Roberto Attanasio, Alberto Boriano, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 21, 2020
False Positive of <sup>68</sup>Ga-DOTATATE PET-CT in a ParagangliomaBenedetta Zampetti, Roberto Attanasio, Marco Boniardi, et al.
Clinical Endocrinology|July 27, 2004
Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin statusRenato Cozzi, Roberto Attanasio, Sandro Lodrini, et al.
Journal of the Endocrine Society|November 21, 2019
Clinical Presentation of Primary Hyperparathyroidism in Older AdultsElena Castellano, Roberto Attanasio, Alberto Boriano, et al.
Pageof 10